KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Return on Invested Capital (2020 - 2025)

Historic Return on Invested Capital for Rigel Pharmaceuticals (RIGL) over the last 5 years, with Q3 2025 value amounting to 0.94%.

  • Rigel Pharmaceuticals' Return on Invested Capital changed N/A to 0.94% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.94%, marking a year-over-year change of. This contributed to the annual value of 4.24% for FY2024, which is N/A changed from last year.
  • Rigel Pharmaceuticals' Return on Invested Capital amounted to 0.94% in Q3 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Return on Invested Capital registered a high of 6.72% during Q3 2022, and its lowest value of 51.4% during Q2 2022.
  • Over the past 4 years, Rigel Pharmaceuticals' median Return on Invested Capital value was 0.17% (recorded in 2021), while the average stood at 5.14%.
  • Examining YoY changes over the last 5 years, Rigel Pharmaceuticals' Return on Invested Capital showed a top increase of 68900bps in 2022 and a maximum decrease of -513400bps in 2022.
  • Quarter analysis of 4 years shows Rigel Pharmaceuticals' Return on Invested Capital stood at 0.32% in 2021, then surged by 2183bps to 6.72% in 2022, then tumbled by -268bps to 11.29% in 2024, then soared by 108bps to 0.94% in 2025.
  • Its Return on Invested Capital was 0.94% in Q3 2025, compared to 1.5% in Q2 2025 and 1.95% in Q1 2025.